Tweet
<img alt="" height="1" width="1" />
Celgene's Abraxane Extends Life By 1.8 Months In Advanced Pancreatic Cancer
Forbes
Abraxane, a cancer chemotherapy made by Celgene, slowed tumor growth and cut the risk of death in patients with advanced pancreatic cancer, according to results that will be presented at a conference on gastrointestinal tumors being held by the American ...
Celgene's Abraxane Benefits Pancreatic Cancer PatientsBloomberg
Celgene Says Pancreatic Cancer Drug Extends Life by Nearly 2 MonthsNASDAQ
Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer TrialTheStreet.com
Medical Xpress -dailyRx -Financial Post
all 31 news articles »
More...